Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Hepatitis C drugs negotiated by a pharmacy benefit manager for Medicare Part D were lower in cost than in price-controlled European countries and Japan in 2015, according to a new report done by IMS Health for Pharmaceutical Care Management Association.
Following the FDA's approval Monday of its muscular dystrophy drug, Cambridge, Mass.-based Sarepta Therapeutics plans to sell up to $255 million of stock and use the proceeds to fund clinical trials, drug commercialization and manufacturing, according to The Wall Street…
Data is a vital asset for improving today’s healthcare supply chain. But not just any data. Healthcare providers need access to information that delivers accurate, insightful comparisons of the multitude of products and manufacturers used in their systems in order…
Carola Endicott, VP Services & Operations, Cardinal Healthâ„¢ Inventory Management Solutions
August trucking volumes show the industry may have recovered after months of low freight demand, according to The Wall Street Journal.
Many professionals in the healthcare industry have called for the inclusion of medical devices' unique device identifiers in health insurance claims.
After a months-long review process that sparked a heated internal debate, the Food and Drug Administration Monday approved eteplirsen as the first treatment for Duchenne muscular dystrophy, a rare disease that causes muscle weakness, loss of movement and eventually death,…
Gayle Manchin, mother of Mylan CEO Heather Bresch, allegedly used her role as director of the National Association of State Boards of Education to boost school EpiPen sales, according to USA Today.
The Senate Finance Committee called for an investigation Tuesday into the oversight of Mylan's Medicaid rebates, reported Reuters.
The Food and Drug Administration recently approved Belgium-based Janssen Pharmaceuticals' drug Invokamet XR for first-line use to improve glycemic control in diabetic adults when paired with diet and exercise.
The House Energy and Commerce Committee opened an investigation on the Food and Drug Administration's Office of Criminal Investigations, citing concerns over management issues and employee morale, reported Reuters.